DNB Financial Group has launched AI-powered platforms for automation and cybersecurity in modern enterprises, while Creative Biolabs introduced a platform to accelerate the development of non-IgG antibodies for biomedical research, using advanced technologies and specialized services to enhance efficacy and druggability.